claim
Senomorphics, also known as SASP inhibitors, target pathways such as p38 MAPK, JAK/STAT, and interleukins to attenuate the senescence-associated secretory phenotype (SASP) of senescent cells.

Authors

Sources

Referenced by nodes (2)